RhAPPcast
This is the official podcast of Rheumatology Advanced Practice Providers (RhAPP), a non-profit 501c3 organization dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).
Through our peer-to-peer network, we seek to support the integral role APPs play in the rheumatology healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with rheumatic diseases.
Podcasting since 2023 • 58 episodes
RhAPPcast
Latest Episodes
Med. Review Video Module: What is the efficacy of ixekizumab across the GRAPPA & EULAR domains?
Join Jessica Farrell, PharmD, a clinical pharmacist and board member of RhAPP, as she breaks down the efficacy of ixekizumab across the GRAPPA domains. In this video, she covers the impact of ixekizumab on peripheral arthritis, axial disease, e...
•
7:25
.png)
Medication Review Video Module: What is the safety profile of guselkumab in PsO and PsA?
Join Cassie Dolecki, a clinical pharmacy specialist in Rheumatology at Allegheny Health Network in Pittsburgh, Pennsylvania, as she discusses the safety profile of guselkumab in treating psoriatic arthritis and psoriasis. Cassie highlights find...
•
2:23
.png)
FAQ: How does axial PsA differ from AS clinically, genetically, and radiographically
Join Kyle George, a physician assistant and member of RhAPP, as he explores the clinical, genetic, and radiographic differences between axial psoriatic arthritis (Axial PsA) and ankylosing spondylitis (AS). In this FAQ session, Kyle provides in...
•
2:31
Journal Club Video Module
Join Jessica Farrell, a clinical pharmacist at Albany Medical Center's Division of Rheumatology and faculty member at Albany College of Pharmacy and Health Sciences, as she discusses a significant study published in "Rheumatology and Therapy" i...
•
3:53
RhAPPcast: Navigating the Complexities: IL-17 Inhibitors and IBD Risk
In this episode of RhAPPcast, host Amanda Mixon, PA-C, dives into the complexities of IL-17 inhibitors and their association with inflammatory bowel disease (IBD). Joined by Candace Ryan, a seasoned rheumatology expert, they explore the benefit...
•
31:12
